About 2,205 results

ALLMedicine™ Angiosarcoma Center

Research & Reviews  817 results

Comparison of the oncogenomic landscape of canine and feline hemangiosarcoma shows nove...
Disease Models & Mechanisms; Wong K, Ludwig L et. al.

Jul 24th, 2021 - Angiosarcoma (AS) is a highly aggressive tumor of blood and lymphatic vessels in humans that shares many similarities with spontaneously occurring hemangiosarcoma (HSA) in dogs and cats. To investigate the genetic suitability of HSA as a model for...

Pulmonary angiosarcoma: A case report of surgical treatment.
Journal of Cardiac Surgery; Edemskiy A, Vasiltseva O et. al.

Jul 23rd, 2021 - Pulmonary angiosarcoma (PAS) is a malignant tumor of the vascular wall of mesenchymal origin. PAS is rare and has unknown etiology and poor prognosis. Depending on the location, angiosarcoma can lead to serious obstructive and embolic complication...

The value of multimodal imaging in the diagnosis of primary cardiac angiosarcoma.
Echocardiography (Mount Kisco, N.Y.); Xu C, Sun W et. al.

Jul 22nd, 2021 - A primary cardiac angiosarcoma (PCA) is very rare, highly aggressive, and metastatic in nature. The manifestations are often nonspecific, and the overall prognosis is extremely poor. The diagnosis of PCA can be complex and remains challenging. The...

Is primary hepatic angiosarcoma in children an indication for liver transplantation?-A ...
Pediatric Transplantation; Aldén J, Baecklund F et. al.

Jul 22nd, 2021 - PHA in the paediatric population is an extremely rare and aggressive malignant soft tissue neoplasm, with less than 50 cases published worldwide. The prognosis is dismal. If the tumour is unresectable, one treatment option is LT. In this article, ...

An open-label single-arm phase II study of regorafenib for the treatment of angiosarcoma.
European Journal of Cancer (Oxford, England : 1990); Agulnik M, Schulte B et. al.

Jul 21st, 2021 - Angiosarcomas represents a diverse group of aggressive high-grade vascular tumours with limited therapeutic options. We sought to determine the safety and efficacy of regorafenib, a small-molecule multikinase inhibitor, in the treatment of metasta...

see more →

Clinicaltrials.gov  10 results

Eribulin in Angiosarcoma and Epithelioid Hemangioendothelioma (EHE)

Nov 15th, 2019 - This research study is a Phase II clinical trial. Phase II clinical trials test the safety and effectiveness of an investigational drug to learn whether the drug works in treating a specific disease. "Investigational" means that the drug is being ...

Efficacity of Weekly Paclitaxel in Association or Not With Bevacizumab in Metastatic or Locally Advanced Angiosarcomas

May 30th, 2019 - Randomization is stratified : angiosarcoma in irradiated region : yes / no visceral angiosarcoma : yes / no All patient will received a maximum of 6 cycles of weekly Paclitaxel (Arm A and B) in association or not with Bevacizumab (ArmB). 1 cycle =...

Clinical and Biological Activity of an Anti-PD-L1 (Atezolizumab) in Operable Localised Soft Tissue Sarcomas Patients to be Treated With Radiotherapy

Sep 28th, 2018 - This trial is a European, multicenter, open-label, randomized, Phase II trial using a pick-the-winner design aiming to the clinical and biological activity of anti-PD-L1 (atezolizumab) in a population of operable localised soft tissue sarcomas (ST...

Daily Oral Regorafenib for Chemotherapy-Refractory, Metastatic and Locally Advanced Angiosarcoma

Sep 11th, 2018 - PRIMARY OBJECTIVES: I. To define the progression-free survival (PFS) at 4 months with daily oral regorafenib (160 mg) in previously treated locally advanced/metastatic angiosarcoma patients SECONDARY OBJECTIVES: I. Progression-free rate at 3 and 6...

Cytological Diagnosis of Hepatic Angiosarcoma and Its Histopathologic Correlation

Dec 18th, 2017 - Hepatic angiosarcoma is a rare hepatic malignant tumor. Although diagnosis of hepatic angiosarcoma by FNA cytology has been reported since 1982, followed by several studies, its cytomorphologic features were still not well recognized by cytopathol...

see more →

News  46 results

Angiosarcoma Imitating a Morpheaform Basal Cell Carcinoma
Elizabeth Veasey, MD, Soon Bahrami, MD et. al.

Mar 2nd, 2020 - To the Editor: Basal cell carcinoma (BCC) is the most common of the nonmelanoma skin cancers and is a highly curable skin growth. 1,2 Conversely, angiosarcomas are aggressive vascular tumors of endothelial origin that classically appear as reddish.

Bleeding Hand Mass in an Older Man
Artem M. Sergeyenko, MD, Leigh Stone, MD et. al.

Feb 14th, 2020 - The Diagnosis: Epithelioid Angiosarcoma Histopathology showed a large soft-tissue neoplasm with extensive hemorrhage (Figure 1). The epithelioid angiosarcoma (EA) consisted mostly of irregular slit-shaped vessels lined by sheets of atypical endoth.

Ill-Defined Macule on the Abdomen
Claire O. Dorfman, DO, Nektarios Lountzis, MD et. al.

Jul 11th, 2019 - The Diagnosis: Microvenular Hemangioma Microvenular hemangioma is an acquired benign vascular neoplasm that was described by Hunt et al1 in 1991, though Bantel et al2 reported a similar entity termed micropapillary angioma in 1989. Microvenular he.

A right atrial mass
Zeel Shah, MD, M. Chadi Alraies, MD et. al.

Jul 1st, 2019 - Figure 1. Computed tomography of the chest.

see more →

Patient Education  9 results see all →